Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations

 

  • Analysts at JMP Securities initiated coverage on Myovant Sciences Ltd (NYSE: MYOV) with a Market Outperform rating. The price target for Myovant Sciences is set to $23. Myovant Sciences shares closed at $11.25 on Friday.
  • Analysts at Brean Capital initiated coverage on Netflix, Inc. (NASDAQ: NFLX) with a Buy rating. The price target for Netflix is set to $145. Netflix shares closed at $115.21 on Friday.
  • Analysts at Goldman Sachs initiated coverage of International Flavors & Fragrances Inc (NYSE: IFF) with a Neutral rating. The price target for International Flavors & Fragrances is set to $121.50. International Flavors & Fragrances shares closed at $119.78 on Friday.
  • Analysts at SunTrust Robinson Humphrey initiated coverage on Ra Pharmaceuticals Inc (NASDAQ: RARX) with a Buy rating. The price target for Ra Pharmaceuticals is set to $32. Ra Pharmaceuticals shares closed at $13.29 on Friday.
  • Morgan Stanley initiated coverage on ZTO Express (Cayman) Inc (ADR) (NYSE: ZTO) with a Overweight rating. The price target for ZTO Express is set to $20. ZTO Express shares closed at $16.30 on Friday.
  • Analysts at Cowen & Co initiated coverage on Sito Mobile Ltd (NASDAQ: SITO) with a Outperform rating. The price target for Sito Mobile is set to $6. Sito Mobile shares closed at $3.92 on Friday.
  • Analysts at Barclays initiated coverage on Myovant Sciences Ltd (NYSE: MYOV) with a Overweight rating. The price target for Myovant Sciences is set to $18. Myovant Sciences shares closed at $11.25 on Friday.
  • Analysts at Stifel Nicolaus initiated coverage on Teekay LNG Partners L.P. (NYSE: TGP) with a Hold rating. The price target for Teekay LNG Partners is set to $14.50. Teekay LNG Partners shares closed at $14.05 on Friday.
  • Credit Suisse initiated coverage on > Ra Pharmaceuticals Inc (NASDAQ: RARX) with a Outperform rating. The price target for Ra Pharmaceuticals is set to $19. Ra Pharmaceuticals shares closed at $13.29 on Friday.
  • H.C. Wainwright initiated coverage on Kite Pharma Inc (NASDAQ: KITE) with a Buy rating. The price target for Kite Pharma is set to $78. Kite Pharma shares closed at $51.80 on Friday.

Latest Ratings for MYOV

DateFirmActionFromTo
Jan 2021SVB LeerinkDowngradesOutperformMarket Perform
Jan 2021Goldman SachsDowngradesBuyNeutral
Aug 2020SVB LeerinkMaintainsOutperform

View More Analyst Ratings for MYOV
View the Latest Analyst Ratings

 

Related Articles (NFLX + MYOV)

View Comments and Join the Discussion!

Posted-In: Top InitiationsInitiation Analyst Ratings

Latest Ratings

StockFirmActionPT
MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
NVDASusquehannaMaintains625.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com